PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test sale cost 4400 AED
REEP2 Gene SPG72 Genetic Test sale cost 4400 AED REEP2 Gene SPG72 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ATXN3 Gene Spinocerebellar Ataxia Type 3 Autosomal Dominant Genetic Test sale cost 4400 AED ATXN3 Gene Spinocerebellar Ataxia Type 3 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PDYN gene Spinocerebellar Ataxia Type 23 (SCA23) Autosomal Dominant Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PDYN gene that are associated with SCA23. Spinocerebellar ataxia type 23 is a neurodegenerative disorder characterized by progressive problems with movement, typically emerging in adulthood. The condition is inherited in an autosomal dominant pattern, meaning that a mutation in just one copy of the relevant gene in each cell is sufficient to cause the disorder.

The test involves analyzing the patient’s DNA to look for specific genetic changes in the PDYN gene that are known to cause SCA23. This genetic testing is crucial for the accurate diagnosis of the condition, which can help in planning the appropriate management and treatment strategies for affected individuals. Additionally, it can provide essential information for family planning and genetic counseling for families affected by SCA23.

At DNA Labs UAE, the cost of the PDYN gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test is set at 4400 AED. This comprehensive testing service not only offers a crucial diagnostic tool for patients and their families but also provides the peace of mind that comes with understanding one’s genetic health landscape.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test

Welcome to DNA Labs UAE, a leading genetic laboratory offering comprehensive genetic testing services. In this blog, we will discuss the PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test, including its cost, symptoms, diagnosis, and other important details.

Test Name: PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information:

Before undergoing the PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant.

Test Details:

PDYN Gene Spinocerebellar Ataxia Type 23 is a genetic disorder characterized by the progressive degeneration of the cerebellum, leading to coordination and balance difficulties. This condition is autosomal dominant, meaning that individuals with one copy of the mutated gene will develop the disorder.

NGS (Next-Generation Sequencing) genetic testing is the method used to analyze multiple genes simultaneously to identify mutations or variations associated with a specific genetic disorder. In the case of Spinocerebellar Ataxia Type 23, NGS genetic testing can identify mutations in the PDYN gene responsible for causing the condition.

NGS genetic testing involves sequencing an individual’s DNA to identify any variations or mutations in specific genes. This helps diagnose Spinocerebellar Ataxia Type 23 and can also be used for carrier testing or prenatal testing in families with a known history of the condition.

It is important to note that NGS genetic testing may not be available in all healthcare settings and may require a referral to a specialized genetics clinic or laboratory. Additionally, genetic testing should always be accompanied by genetic counseling to help individuals understand the implications of the results and make informed decisions regarding their health and reproductive choices.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. If you have any questions or would like to schedule a PDYN Gene Spinocerebellar Ataxia Type 23 Autosomal Dominant Genetic Test, please contact our team.

Test Name PDYN Gene Spinocerebellar ataxia type 23 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PDYN Gene Spinocerebellar ataxia type 23, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PDYN Gene Spinocerebellar ataxia type 23, autosomal dominant
Test Details

PDYN gene spinocerebellar ataxia type 23 is a genetic disorder characterized by progressive degeneration of the cerebellum, resulting in difficulties with coordination and balance. It is an autosomal dominant disorder, which means that individuals with one copy of the mutated gene will develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular genetic disorder. In the case of spinocerebellar ataxia type 23, NGS genetic testing can be used to identify mutations in the PDYN gene that are responsible for causing the condition.

NGS genetic testing involves sequencing the DNA of an individual to identify any variations or mutations in specific genes. This can help in the diagnosis of spinocerebellar ataxia type 23 and can also be used for carrier testing or prenatal testing in families with a known history of the condition.

It is important to note that NGS genetic testing may not be available in all healthcare settings and may require a referral to a specialized genetics clinic or laboratory. Additionally, genetic testing should always be accompanied by genetic counseling to help individuals understand the implications of the results and make informed decisions about their health and reproductive choices.

SKU: TEST-2067